Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in greater weight loss and better glucose lowering than medications that target GLP-1 alone, said Isaacs
For tirzepatide versus semaglutide, contrary to the primary endpoint in the head-to-head comparison, there was some supporting evidence for tirzepatide to have a modest benefit, although the 95% CI overlapped the null (HR 0.91, 95% CI 0.81 to 1.01) (Fig
A result can be statistically compelling and still not be practice-changing
Structural characterization of ribT from Bacillus subtilis reveals it as a GCN5-related N-acetyltransferase
Patients with prior acute pancreatitis can sometimes use semaglutide under close monitoring, though chronic pancreatitis warrants specialist evaluation first
Weight loss velocity peaked during weeks 12 through 24, with participants losing approximately 1.7 pounds per week during this acceleration phase